Company news
CorMedix Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
CorMedix Announces Pricing of $20M Public Offering of Common Stock
July 27, 2020
CorMedix Announces Proposed Public Offering of Common Stock
July 26, 2020
CorMedix Inc. Reports Submission of Defencath™ New Drug Application
July 7, 2020
CorMedix Inc. Reports First Quarter 2020 Financial Results and Provides Business Update
May 10, 2020
CorMedix Inc. Announces Appointment of Chief Financial Officer
May 10, 2020
CorMedix Hosting KOL Call on Antimicrobial Resistance, Catheter-Related Bloodstream Infections (CRBSIs), and the Potential for Neutrolin®
May 5, 2020
CorMedix Inc. to Report First Quarter 2020 Financial Results and Provide a Corporate Update on May 11
May 3, 2020
CorMedix Inc. Announces Contract Extension of Jack Armstrong as Executive Vice President and Head of Technical Operations
April 22, 2020
CorMedix Completes Sale of $5.5 Million of NOL Tax Benefits through New Jersey Technology Business Tax Certificate Transfer Program
April 21, 2020
CorMedix Inc. reports fourth quarter and full year 2019 financial results and provides business update
March 15, 2020
CorMedix Inc. to Report Fourth Quarter 2019 Financial Results and Provide a Corporate Update on March 16
March 5, 2020
CorMedix Inc. Announces FDA Grant of Rolling Review of Neutrolin® New Drug Application
February 2, 2020
CorMedix Approved to Sell $5.5 Million of NOL Tax Benefits Through the New Jersey Economic Development Authority Program
February 2, 2020
CorMedix Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update
November 13, 2019
CorMedix Inc. to Report Third Quarter 2019 Financial Results and Provide a Corporate Update on November 14
November 6, 2019
CorMedix Inc. Announces a Change to its Senior Leadership
November 5, 2019
CorMedix Completes Sale of $5.4 Million of NOL Tax Benefits Through New Jersey Economic Development Authority Program
April 16, 2019
Calls
The 5 newest of 21 calls. Every call is listed under its year.
- Cormedix (NASDAQ:CRMD) Q2 2026 Earnings Call
Aug 13, 2026
Transcript - Cormedix (NASDAQ:CRMD) Q1 2026 Earnings Call
May 14, 2026
Transcript - Cormedix (NASDAQ:CRMD) Q4 2025 Earnings Call
Mar 5, 2026
Transcript - Cormedix (NASDAQ:CRMD) Q3 2025 Earnings Call
Nov 12, 2025
Transcript - Cormedix (NASDAQ:CRMD) Q2 2025 Earnings Call
Aug 7, 2025
Transcript
Decks
The 5 newest of 28 decks. Every deck is listed under its year.
- Technical Presentation (October 2026)
Technical · 16 slides · October 2026
- CorMedix Therapeutics — Investor Presentation (September 2026)
Investor deck · 25 slides · September 2026
- CorMedix Therapeutics — Investor Presentation (May 2026)
Investor deck · 24 slides · May 2026
- Investor Presentation (March 2026)
Investor deck · 23 slides · Mar 6, 2026
- CorMedix Therapeutics — Investor Day (February 2026)
Investor day · 50 slides · Feb 10, 2026